Ubs Asset Management Americas Inc Vanda Pharmaceuticals Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$4.28 - $6.57 $52,682 - $80,870
-12,309 Reduced 14.78%
71,000 $306,000
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $143,122 - $185,040
23,159 Added 38.5%
83,309 $565,000
Q3 2021

Nov 15, 2021
BUY
$15.35 - $21.27 $188,943 - $261,812
12,309 Added 25.73%
60,150 $1.03 Million
Q2 2021

Aug 16, 2021
BUY
$15.71 - $21.51 $103,403 - $141,578
6,582 Added 15.95%
47,841 $1.03 Million
Q1 2021

May 14, 2021
SELL
$13.42 - $20.28 $88,451 - $133,665
-6,591 Reduced 13.77%
41,259 $619,000
Q2 2020

Aug 14, 2020
BUY
$9.66 - $12.02 $27,183 - $33,824
2,814 Added 6.25%
47,850 $547,000
Q1 2020

May 15, 2020
BUY
$7.5 - $16.8 $39,697 - $88,922
5,293 Added 13.32%
45,036 $466,000
Q4 2019

Feb 14, 2020
SELL
$12.38 - $17.47 $60,822 - $85,830
-4,913 Reduced 11.0%
39,743 $652,000
Q3 2019

Nov 14, 2019
BUY
$12.27 - $15.79 $126,736 - $163,094
10,329 Added 30.09%
44,656 $593,000
Q2 2019

Aug 15, 2019
BUY
$13.37 - $18.85 $216,206 - $304,823
16,171 Added 89.07%
34,327 $0
Q1 2019

May 14, 2019
BUY
$17.59 - $31.05 $83,235 - $146,928
4,732 Added 35.25%
18,156 $0
Q4 2018

Feb 13, 2019
BUY
$18.97 - $31.47 $254,653 - $422,453
13,424 New
13,424 $350,000

Others Institutions Holding VNDA

# of Institutions
157
Shares Held
44.9M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email